Research ArticleArticle
High Reproducibility of an Automated Measurement of Mobility for Patients with Axial Spondyloarthritis
Juan L. Garrido-Castro, Rafael Curbelo, Ramón Mazzucchelli, María E. Domínguez-González, Cristina Gonzalez-Navas, Bryan J. Flores Robles, Pedro Zarco, Juan Mulero, Luis Cea-Calvo, María J. Arteaga, Pilar Font-Ugalde, Loreto Carmona and Eduardo Collantes-Estevez
The Journal of Rheumatology June 2018, jrheum.170941; DOI: https://doi.org/10.3899/jrheum.170941
Juan L. Garrido-Castro
From the Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC); Department of Rheumatology, Hospital Universitario Reina Sofía; Department of Medicine, Universidad de Córdoba, Córdoba; Instituto de Salud Musculoesquelética; Department of Rheumatology, Hospital Fundación Alcorcón, Alcorcón; Department of Rheumatology, Hospital Puerta de Hierro, Majadahonda; Medical Affairs, Merck Sharp & Dohme, Madrid, Spain. Study funded by Merck Sharp & Dohme of Spain. Dr. L. Cea-Calvo and Dr. M.J. Arteaga are full-time employees at Merck Sharp & Dohme of Spain. UCOTrack is owned by the University of Córdoba and the Andalusian Health Service. J.L. Garrido-Castro, IE, PhD, IMIBIC; R. Curbelo, PT, PhD, Instituto de Salud Musculoesquelética; R. Mazzucchelli, MD, Department of Rheumatology, Hospital Fundación Alcorcón; M.E. Domínguez-González, RN, Department of Rheumatology, Hospital Fundación Alcorcón; C. Gonzalez-Navas, RN, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía; B.J. Flores Robles, MD, Department of Rheumatology, Hospital Puerta de Hierro; P. Zarco, MD, PhD, Department of Rheumatology, Hospital Fundación Alcorcón; J. Mulero, MD, PhD, Department of Rheumatology, Hospital Puerta de Hierro; L. Cea-Calvo, MD, Medical Affairs, Merck Sharp & Dohme; M.J. Arteaga, MD, Medical Affairs, Merck Sharp & Dohme; P. Font-Ugalde, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba; L. Carmona, MD, PhD, Instituto de Salud Musculoesquelética; E. Collantes-Estevez, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba. Address correspondence to Dr. J.L. Garrido-Castro, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. E-mail: cc0juanl@uco.es. Accepted for publication February 28, 2018.
Rafael Curbelo
From the Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC); Department of Rheumatology, Hospital Universitario Reina Sofía; Department of Medicine, Universidad de Córdoba, Córdoba; Instituto de Salud Musculoesquelética; Department of Rheumatology, Hospital Fundación Alcorcón, Alcorcón; Department of Rheumatology, Hospital Puerta de Hierro, Majadahonda; Medical Affairs, Merck Sharp & Dohme, Madrid, Spain. Study funded by Merck Sharp & Dohme of Spain. Dr. L. Cea-Calvo and Dr. M.J. Arteaga are full-time employees at Merck Sharp & Dohme of Spain. UCOTrack is owned by the University of Córdoba and the Andalusian Health Service. J.L. Garrido-Castro, IE, PhD, IMIBIC; R. Curbelo, PT, PhD, Instituto de Salud Musculoesquelética; R. Mazzucchelli, MD, Department of Rheumatology, Hospital Fundación Alcorcón; M.E. Domínguez-González, RN, Department of Rheumatology, Hospital Fundación Alcorcón; C. Gonzalez-Navas, RN, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía; B.J. Flores Robles, MD, Department of Rheumatology, Hospital Puerta de Hierro; P. Zarco, MD, PhD, Department of Rheumatology, Hospital Fundación Alcorcón; J. Mulero, MD, PhD, Department of Rheumatology, Hospital Puerta de Hierro; L. Cea-Calvo, MD, Medical Affairs, Merck Sharp & Dohme; M.J. Arteaga, MD, Medical Affairs, Merck Sharp & Dohme; P. Font-Ugalde, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba; L. Carmona, MD, PhD, Instituto de Salud Musculoesquelética; E. Collantes-Estevez, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba. Address correspondence to Dr. J.L. Garrido-Castro, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. E-mail: cc0juanl@uco.es. Accepted for publication February 28, 2018.
Ramón Mazzucchelli
From the Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC); Department of Rheumatology, Hospital Universitario Reina Sofía; Department of Medicine, Universidad de Córdoba, Córdoba; Instituto de Salud Musculoesquelética; Department of Rheumatology, Hospital Fundación Alcorcón, Alcorcón; Department of Rheumatology, Hospital Puerta de Hierro, Majadahonda; Medical Affairs, Merck Sharp & Dohme, Madrid, Spain. Study funded by Merck Sharp & Dohme of Spain. Dr. L. Cea-Calvo and Dr. M.J. Arteaga are full-time employees at Merck Sharp & Dohme of Spain. UCOTrack is owned by the University of Córdoba and the Andalusian Health Service. J.L. Garrido-Castro, IE, PhD, IMIBIC; R. Curbelo, PT, PhD, Instituto de Salud Musculoesquelética; R. Mazzucchelli, MD, Department of Rheumatology, Hospital Fundación Alcorcón; M.E. Domínguez-González, RN, Department of Rheumatology, Hospital Fundación Alcorcón; C. Gonzalez-Navas, RN, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía; B.J. Flores Robles, MD, Department of Rheumatology, Hospital Puerta de Hierro; P. Zarco, MD, PhD, Department of Rheumatology, Hospital Fundación Alcorcón; J. Mulero, MD, PhD, Department of Rheumatology, Hospital Puerta de Hierro; L. Cea-Calvo, MD, Medical Affairs, Merck Sharp & Dohme; M.J. Arteaga, MD, Medical Affairs, Merck Sharp & Dohme; P. Font-Ugalde, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba; L. Carmona, MD, PhD, Instituto de Salud Musculoesquelética; E. Collantes-Estevez, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba. Address correspondence to Dr. J.L. Garrido-Castro, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. E-mail: cc0juanl@uco.es. Accepted for publication February 28, 2018.
María E. Domínguez-González
From the Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC); Department of Rheumatology, Hospital Universitario Reina Sofía; Department of Medicine, Universidad de Córdoba, Córdoba; Instituto de Salud Musculoesquelética; Department of Rheumatology, Hospital Fundación Alcorcón, Alcorcón; Department of Rheumatology, Hospital Puerta de Hierro, Majadahonda; Medical Affairs, Merck Sharp & Dohme, Madrid, Spain. Study funded by Merck Sharp & Dohme of Spain. Dr. L. Cea-Calvo and Dr. M.J. Arteaga are full-time employees at Merck Sharp & Dohme of Spain. UCOTrack is owned by the University of Córdoba and the Andalusian Health Service. J.L. Garrido-Castro, IE, PhD, IMIBIC; R. Curbelo, PT, PhD, Instituto de Salud Musculoesquelética; R. Mazzucchelli, MD, Department of Rheumatology, Hospital Fundación Alcorcón; M.E. Domínguez-González, RN, Department of Rheumatology, Hospital Fundación Alcorcón; C. Gonzalez-Navas, RN, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía; B.J. Flores Robles, MD, Department of Rheumatology, Hospital Puerta de Hierro; P. Zarco, MD, PhD, Department of Rheumatology, Hospital Fundación Alcorcón; J. Mulero, MD, PhD, Department of Rheumatology, Hospital Puerta de Hierro; L. Cea-Calvo, MD, Medical Affairs, Merck Sharp & Dohme; M.J. Arteaga, MD, Medical Affairs, Merck Sharp & Dohme; P. Font-Ugalde, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba; L. Carmona, MD, PhD, Instituto de Salud Musculoesquelética; E. Collantes-Estevez, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba. Address correspondence to Dr. J.L. Garrido-Castro, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. E-mail: cc0juanl@uco.es. Accepted for publication February 28, 2018.
Cristina Gonzalez-Navas
From the Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC); Department of Rheumatology, Hospital Universitario Reina Sofía; Department of Medicine, Universidad de Córdoba, Córdoba; Instituto de Salud Musculoesquelética; Department of Rheumatology, Hospital Fundación Alcorcón, Alcorcón; Department of Rheumatology, Hospital Puerta de Hierro, Majadahonda; Medical Affairs, Merck Sharp & Dohme, Madrid, Spain. Study funded by Merck Sharp & Dohme of Spain. Dr. L. Cea-Calvo and Dr. M.J. Arteaga are full-time employees at Merck Sharp & Dohme of Spain. UCOTrack is owned by the University of Córdoba and the Andalusian Health Service. J.L. Garrido-Castro, IE, PhD, IMIBIC; R. Curbelo, PT, PhD, Instituto de Salud Musculoesquelética; R. Mazzucchelli, MD, Department of Rheumatology, Hospital Fundación Alcorcón; M.E. Domínguez-González, RN, Department of Rheumatology, Hospital Fundación Alcorcón; C. Gonzalez-Navas, RN, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía; B.J. Flores Robles, MD, Department of Rheumatology, Hospital Puerta de Hierro; P. Zarco, MD, PhD, Department of Rheumatology, Hospital Fundación Alcorcón; J. Mulero, MD, PhD, Department of Rheumatology, Hospital Puerta de Hierro; L. Cea-Calvo, MD, Medical Affairs, Merck Sharp & Dohme; M.J. Arteaga, MD, Medical Affairs, Merck Sharp & Dohme; P. Font-Ugalde, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba; L. Carmona, MD, PhD, Instituto de Salud Musculoesquelética; E. Collantes-Estevez, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba. Address correspondence to Dr. J.L. Garrido-Castro, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. E-mail: cc0juanl@uco.es. Accepted for publication February 28, 2018.
Bryan J. Flores Robles
From the Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC); Department of Rheumatology, Hospital Universitario Reina Sofía; Department of Medicine, Universidad de Córdoba, Córdoba; Instituto de Salud Musculoesquelética; Department of Rheumatology, Hospital Fundación Alcorcón, Alcorcón; Department of Rheumatology, Hospital Puerta de Hierro, Majadahonda; Medical Affairs, Merck Sharp & Dohme, Madrid, Spain. Study funded by Merck Sharp & Dohme of Spain. Dr. L. Cea-Calvo and Dr. M.J. Arteaga are full-time employees at Merck Sharp & Dohme of Spain. UCOTrack is owned by the University of Córdoba and the Andalusian Health Service. J.L. Garrido-Castro, IE, PhD, IMIBIC; R. Curbelo, PT, PhD, Instituto de Salud Musculoesquelética; R. Mazzucchelli, MD, Department of Rheumatology, Hospital Fundación Alcorcón; M.E. Domínguez-González, RN, Department of Rheumatology, Hospital Fundación Alcorcón; C. Gonzalez-Navas, RN, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía; B.J. Flores Robles, MD, Department of Rheumatology, Hospital Puerta de Hierro; P. Zarco, MD, PhD, Department of Rheumatology, Hospital Fundación Alcorcón; J. Mulero, MD, PhD, Department of Rheumatology, Hospital Puerta de Hierro; L. Cea-Calvo, MD, Medical Affairs, Merck Sharp & Dohme; M.J. Arteaga, MD, Medical Affairs, Merck Sharp & Dohme; P. Font-Ugalde, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba; L. Carmona, MD, PhD, Instituto de Salud Musculoesquelética; E. Collantes-Estevez, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba. Address correspondence to Dr. J.L. Garrido-Castro, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. E-mail: cc0juanl@uco.es. Accepted for publication February 28, 2018.
Pedro Zarco
From the Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC); Department of Rheumatology, Hospital Universitario Reina Sofía; Department of Medicine, Universidad de Córdoba, Córdoba; Instituto de Salud Musculoesquelética; Department of Rheumatology, Hospital Fundación Alcorcón, Alcorcón; Department of Rheumatology, Hospital Puerta de Hierro, Majadahonda; Medical Affairs, Merck Sharp & Dohme, Madrid, Spain. Study funded by Merck Sharp & Dohme of Spain. Dr. L. Cea-Calvo and Dr. M.J. Arteaga are full-time employees at Merck Sharp & Dohme of Spain. UCOTrack is owned by the University of Córdoba and the Andalusian Health Service. J.L. Garrido-Castro, IE, PhD, IMIBIC; R. Curbelo, PT, PhD, Instituto de Salud Musculoesquelética; R. Mazzucchelli, MD, Department of Rheumatology, Hospital Fundación Alcorcón; M.E. Domínguez-González, RN, Department of Rheumatology, Hospital Fundación Alcorcón; C. Gonzalez-Navas, RN, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía; B.J. Flores Robles, MD, Department of Rheumatology, Hospital Puerta de Hierro; P. Zarco, MD, PhD, Department of Rheumatology, Hospital Fundación Alcorcón; J. Mulero, MD, PhD, Department of Rheumatology, Hospital Puerta de Hierro; L. Cea-Calvo, MD, Medical Affairs, Merck Sharp & Dohme; M.J. Arteaga, MD, Medical Affairs, Merck Sharp & Dohme; P. Font-Ugalde, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba; L. Carmona, MD, PhD, Instituto de Salud Musculoesquelética; E. Collantes-Estevez, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba. Address correspondence to Dr. J.L. Garrido-Castro, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. E-mail: cc0juanl@uco.es. Accepted for publication February 28, 2018.
Juan Mulero
From the Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC); Department of Rheumatology, Hospital Universitario Reina Sofía; Department of Medicine, Universidad de Córdoba, Córdoba; Instituto de Salud Musculoesquelética; Department of Rheumatology, Hospital Fundación Alcorcón, Alcorcón; Department of Rheumatology, Hospital Puerta de Hierro, Majadahonda; Medical Affairs, Merck Sharp & Dohme, Madrid, Spain. Study funded by Merck Sharp & Dohme of Spain. Dr. L. Cea-Calvo and Dr. M.J. Arteaga are full-time employees at Merck Sharp & Dohme of Spain. UCOTrack is owned by the University of Córdoba and the Andalusian Health Service. J.L. Garrido-Castro, IE, PhD, IMIBIC; R. Curbelo, PT, PhD, Instituto de Salud Musculoesquelética; R. Mazzucchelli, MD, Department of Rheumatology, Hospital Fundación Alcorcón; M.E. Domínguez-González, RN, Department of Rheumatology, Hospital Fundación Alcorcón; C. Gonzalez-Navas, RN, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía; B.J. Flores Robles, MD, Department of Rheumatology, Hospital Puerta de Hierro; P. Zarco, MD, PhD, Department of Rheumatology, Hospital Fundación Alcorcón; J. Mulero, MD, PhD, Department of Rheumatology, Hospital Puerta de Hierro; L. Cea-Calvo, MD, Medical Affairs, Merck Sharp & Dohme; M.J. Arteaga, MD, Medical Affairs, Merck Sharp & Dohme; P. Font-Ugalde, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba; L. Carmona, MD, PhD, Instituto de Salud Musculoesquelética; E. Collantes-Estevez, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba. Address correspondence to Dr. J.L. Garrido-Castro, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. E-mail: cc0juanl@uco.es. Accepted for publication February 28, 2018.
Luis Cea-Calvo
From the Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC); Department of Rheumatology, Hospital Universitario Reina Sofía; Department of Medicine, Universidad de Córdoba, Córdoba; Instituto de Salud Musculoesquelética; Department of Rheumatology, Hospital Fundación Alcorcón, Alcorcón; Department of Rheumatology, Hospital Puerta de Hierro, Majadahonda; Medical Affairs, Merck Sharp & Dohme, Madrid, Spain. Study funded by Merck Sharp & Dohme of Spain. Dr. L. Cea-Calvo and Dr. M.J. Arteaga are full-time employees at Merck Sharp & Dohme of Spain. UCOTrack is owned by the University of Córdoba and the Andalusian Health Service. J.L. Garrido-Castro, IE, PhD, IMIBIC; R. Curbelo, PT, PhD, Instituto de Salud Musculoesquelética; R. Mazzucchelli, MD, Department of Rheumatology, Hospital Fundación Alcorcón; M.E. Domínguez-González, RN, Department of Rheumatology, Hospital Fundación Alcorcón; C. Gonzalez-Navas, RN, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía; B.J. Flores Robles, MD, Department of Rheumatology, Hospital Puerta de Hierro; P. Zarco, MD, PhD, Department of Rheumatology, Hospital Fundación Alcorcón; J. Mulero, MD, PhD, Department of Rheumatology, Hospital Puerta de Hierro; L. Cea-Calvo, MD, Medical Affairs, Merck Sharp & Dohme; M.J. Arteaga, MD, Medical Affairs, Merck Sharp & Dohme; P. Font-Ugalde, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba; L. Carmona, MD, PhD, Instituto de Salud Musculoesquelética; E. Collantes-Estevez, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba. Address correspondence to Dr. J.L. Garrido-Castro, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. E-mail: cc0juanl@uco.es. Accepted for publication February 28, 2018.
María J. Arteaga
From the Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC); Department of Rheumatology, Hospital Universitario Reina Sofía; Department of Medicine, Universidad de Córdoba, Córdoba; Instituto de Salud Musculoesquelética; Department of Rheumatology, Hospital Fundación Alcorcón, Alcorcón; Department of Rheumatology, Hospital Puerta de Hierro, Majadahonda; Medical Affairs, Merck Sharp & Dohme, Madrid, Spain. Study funded by Merck Sharp & Dohme of Spain. Dr. L. Cea-Calvo and Dr. M.J. Arteaga are full-time employees at Merck Sharp & Dohme of Spain. UCOTrack is owned by the University of Córdoba and the Andalusian Health Service. J.L. Garrido-Castro, IE, PhD, IMIBIC; R. Curbelo, PT, PhD, Instituto de Salud Musculoesquelética; R. Mazzucchelli, MD, Department of Rheumatology, Hospital Fundación Alcorcón; M.E. Domínguez-González, RN, Department of Rheumatology, Hospital Fundación Alcorcón; C. Gonzalez-Navas, RN, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía; B.J. Flores Robles, MD, Department of Rheumatology, Hospital Puerta de Hierro; P. Zarco, MD, PhD, Department of Rheumatology, Hospital Fundación Alcorcón; J. Mulero, MD, PhD, Department of Rheumatology, Hospital Puerta de Hierro; L. Cea-Calvo, MD, Medical Affairs, Merck Sharp & Dohme; M.J. Arteaga, MD, Medical Affairs, Merck Sharp & Dohme; P. Font-Ugalde, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba; L. Carmona, MD, PhD, Instituto de Salud Musculoesquelética; E. Collantes-Estevez, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba. Address correspondence to Dr. J.L. Garrido-Castro, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. E-mail: cc0juanl@uco.es. Accepted for publication February 28, 2018.
Pilar Font-Ugalde
From the Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC); Department of Rheumatology, Hospital Universitario Reina Sofía; Department of Medicine, Universidad de Córdoba, Córdoba; Instituto de Salud Musculoesquelética; Department of Rheumatology, Hospital Fundación Alcorcón, Alcorcón; Department of Rheumatology, Hospital Puerta de Hierro, Majadahonda; Medical Affairs, Merck Sharp & Dohme, Madrid, Spain. Study funded by Merck Sharp & Dohme of Spain. Dr. L. Cea-Calvo and Dr. M.J. Arteaga are full-time employees at Merck Sharp & Dohme of Spain. UCOTrack is owned by the University of Córdoba and the Andalusian Health Service. J.L. Garrido-Castro, IE, PhD, IMIBIC; R. Curbelo, PT, PhD, Instituto de Salud Musculoesquelética; R. Mazzucchelli, MD, Department of Rheumatology, Hospital Fundación Alcorcón; M.E. Domínguez-González, RN, Department of Rheumatology, Hospital Fundación Alcorcón; C. Gonzalez-Navas, RN, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía; B.J. Flores Robles, MD, Department of Rheumatology, Hospital Puerta de Hierro; P. Zarco, MD, PhD, Department of Rheumatology, Hospital Fundación Alcorcón; J. Mulero, MD, PhD, Department of Rheumatology, Hospital Puerta de Hierro; L. Cea-Calvo, MD, Medical Affairs, Merck Sharp & Dohme; M.J. Arteaga, MD, Medical Affairs, Merck Sharp & Dohme; P. Font-Ugalde, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba; L. Carmona, MD, PhD, Instituto de Salud Musculoesquelética; E. Collantes-Estevez, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba. Address correspondence to Dr. J.L. Garrido-Castro, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. E-mail: cc0juanl@uco.es. Accepted for publication February 28, 2018.
Loreto Carmona
From the Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC); Department of Rheumatology, Hospital Universitario Reina Sofía; Department of Medicine, Universidad de Córdoba, Córdoba; Instituto de Salud Musculoesquelética; Department of Rheumatology, Hospital Fundación Alcorcón, Alcorcón; Department of Rheumatology, Hospital Puerta de Hierro, Majadahonda; Medical Affairs, Merck Sharp & Dohme, Madrid, Spain. Study funded by Merck Sharp & Dohme of Spain. Dr. L. Cea-Calvo and Dr. M.J. Arteaga are full-time employees at Merck Sharp & Dohme of Spain. UCOTrack is owned by the University of Córdoba and the Andalusian Health Service. J.L. Garrido-Castro, IE, PhD, IMIBIC; R. Curbelo, PT, PhD, Instituto de Salud Musculoesquelética; R. Mazzucchelli, MD, Department of Rheumatology, Hospital Fundación Alcorcón; M.E. Domínguez-González, RN, Department of Rheumatology, Hospital Fundación Alcorcón; C. Gonzalez-Navas, RN, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía; B.J. Flores Robles, MD, Department of Rheumatology, Hospital Puerta de Hierro; P. Zarco, MD, PhD, Department of Rheumatology, Hospital Fundación Alcorcón; J. Mulero, MD, PhD, Department of Rheumatology, Hospital Puerta de Hierro; L. Cea-Calvo, MD, Medical Affairs, Merck Sharp & Dohme; M.J. Arteaga, MD, Medical Affairs, Merck Sharp & Dohme; P. Font-Ugalde, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba; L. Carmona, MD, PhD, Instituto de Salud Musculoesquelética; E. Collantes-Estevez, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba. Address correspondence to Dr. J.L. Garrido-Castro, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. E-mail: cc0juanl@uco.es. Accepted for publication February 28, 2018.
Eduardo Collantes-Estevez
From the Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC); Department of Rheumatology, Hospital Universitario Reina Sofía; Department of Medicine, Universidad de Córdoba, Córdoba; Instituto de Salud Musculoesquelética; Department of Rheumatology, Hospital Fundación Alcorcón, Alcorcón; Department of Rheumatology, Hospital Puerta de Hierro, Majadahonda; Medical Affairs, Merck Sharp & Dohme, Madrid, Spain. Study funded by Merck Sharp & Dohme of Spain. Dr. L. Cea-Calvo and Dr. M.J. Arteaga are full-time employees at Merck Sharp & Dohme of Spain. UCOTrack is owned by the University of Córdoba and the Andalusian Health Service. J.L. Garrido-Castro, IE, PhD, IMIBIC; R. Curbelo, PT, PhD, Instituto de Salud Musculoesquelética; R. Mazzucchelli, MD, Department of Rheumatology, Hospital Fundación Alcorcón; M.E. Domínguez-González, RN, Department of Rheumatology, Hospital Fundación Alcorcón; C. Gonzalez-Navas, RN, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía; B.J. Flores Robles, MD, Department of Rheumatology, Hospital Puerta de Hierro; P. Zarco, MD, PhD, Department of Rheumatology, Hospital Fundación Alcorcón; J. Mulero, MD, PhD, Department of Rheumatology, Hospital Puerta de Hierro; L. Cea-Calvo, MD, Medical Affairs, Merck Sharp & Dohme; M.J. Arteaga, MD, Medical Affairs, Merck Sharp & Dohme; P. Font-Ugalde, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba; L. Carmona, MD, PhD, Instituto de Salud Musculoesquelética; E. Collantes-Estevez, MD, PhD, IMIBIC, and Department of Rheumatology, Hospital Universitario Reina Sofía, and Department of Medicine, Universidad de Córdoba. Address correspondence to Dr. J.L. Garrido-Castro, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. E-mail: cc0juanl@uco.es. Accepted for publication February 28, 2018.
Abstract
Objective Conventional measures of spinal mobility used in the assessment of patients with axial spondyloarthritis (axSpA), such as the Bath Ankylosing Spondylitis Metrology Index and its components, are subject to interobserver variability. The University of Córdoba Ankylosing Spondylitis Metrology Index (UCOASMI) is a validated composite index based on a motion video-capture system, UCOTrack. Our objective was to assess its reproducibility in clinical practice settings.
Methods We carried out an observational study of repeated measures in 3 centers. Video-capture systems were installed and adapted to clinical rooms. Patients with axSpA and stable disease were selected by consecutive stratified sampling [disease duration, sex, and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)]. Intraobserver reliability of the UCOASMI and of conventional measures was tested 3–5 days apart. For interobserver reliability, 3 patients from each center were evaluated in the other centers, within 3–7 days. The intraclass correlation coefficients (ICC) were calculated.
Results Thirty patients were included (73% men, mean age 53 yrs, mean BASDAI 3.0). Interobserver and intraobserver ICC of the UCOASMI was 0.98. Conventional measurements showed lower but adequate reproducibility as well, except for interobserver reliability of lateral flexion (0.41), cervical rotation (0.61), and Schöber test (0.07), and intraobserver reliability of tragus-to-wall distance (0.30).
Conclusion Reproducibility of the UCOASMI seems very high, and apparently more reliable than conventional measures of mobility.
In this issue
The Journal of Rheumatology
Vol. 49, Issue 8
1 Aug 2022
High Reproducibility of an Automated Measurement of Mobility for Patients with Axial Spondyloarthritis
Juan L. Garrido-Castro, Rafael Curbelo, Ramón Mazzucchelli, María E. Domínguez-González, Cristina Gonzalez-Navas, Bryan J. Flores Robles, Pedro Zarco, Juan Mulero, Luis Cea-Calvo, María J. Arteaga, Pilar Font-Ugalde, Loreto Carmona, Eduardo Collantes-Estevez
The Journal of Rheumatology Jun 2018, jrheum.170941; DOI: 10.3899/jrheum.170941
High Reproducibility of an Automated Measurement of Mobility for Patients with Axial Spondyloarthritis
Juan L. Garrido-Castro, Rafael Curbelo, Ramón Mazzucchelli, María E. Domínguez-González, Cristina Gonzalez-Navas, Bryan J. Flores Robles, Pedro Zarco, Juan Mulero, Luis Cea-Calvo, María J. Arteaga, Pilar Font-Ugalde, Loreto Carmona, Eduardo Collantes-Estevez
The Journal of Rheumatology Jun 2018, jrheum.170941; DOI: 10.3899/jrheum.170941
